Skip to search formSkip to main contentSkip to account menu

phlorofucofuroeckol A

Known as: 1,11-di-(3,5-dihydroxyphenoxy)benzofuro(3,2-a)dibenzo(b,e)(1,4)-dioxin-2,4,8,10,14-pentaol, Benzo(b)benzofuro(3,2-f)(1,4)benzodioxin-1,3,6,10,12-pentol, 4,9-bis(3,5-dihydroxyphenoxy)-, phlorofucofuroeckol-A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
This review focuses on macroalgae-derived compounds with neuroprotective activity that may provide lead compounds for the… 
2014
2014
The influence of phlorotannins and bromophenols on the feeding behavior of marine herbivores was determined using bioassay of… 
2013
2013
The antioxidative properties of phlorotannins isolated from the brown alga Eisenia bicyclis were measured using the H-ORAC… 
2012
2012
Amyloid beta peptide (Aβ) oligomers increase intracellular reactive oxygen species (ROS) and calcium cation (Ca2+) concentrations… 
2012
2012
Since the oxidation of low-density lipoprotein (LDL) is one of the main causes of atherosclerosis, Cu2+-induced LDL oxidation and… 
2012
2012
Microglial activation has been implicated in many neurological disorders for its inflammatory and neurotrophic effects. In this… 
2009
2009
본 발명은 곰피와 감태 추출물 유래의 플로로탄닌을 유효성분으로 함유하는 염증억제용 조성물에 관한 것으로, 특히 에탄올 또는 메탄올 추출물 중 헥산과 에틸아세테이트 획분과 에틸아세테이트 획분에서 분리된 phlorofucofuroeckol A (플로로푸코푸로에콜 에이)는 염증매개인자인 iNOS와 COX-2 발현억제와 이 효소에 의해 생성되는 NO와 PGE 2 의 생성억제에 효능이 있으므로 염증과 관련된 질병을 예방 및 치료하는데 뛰어난 효과가 있다.